This post is the first in a five-part series summarizing APDA’s recent “Ask the Expert” event on Smart Patients. During the ...

Scientists have, for the first time, directly visualized and quantified the protein clusters believed to trigger Parkinson's, marking a major advance in the study of the world's fastest-growing ...

For millions of people worldwide living with tremor, stiffness, and slowness of movement, the question that matters most is deceptively simple: do they have a neurodegenerative parkinsonian syndrome ...

Add Yahoo as a preferred source to see more of our stories on Google. Parkinson's attacks a part of the brain called the substantia nigra. (Kateryna Kon/Science Photo Library/Getty Images) There's a ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work equally well for everyone. By mapping patients’ brain signals before and ...

Rather than seeing Parkinson's as simply the presence or strength of beta activity, the study results support a model in which the precise coordination, timing and direction of dual-signal activity ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new treatment for one type of Parkinson's disease may be on the ...

Deep brain stimulation, a process in which electrodes stimulate specific brain circuits to reduce motor symptoms, has long helped people with Parkinson’s disease manage their tremors — but a new ...

Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...

While there is no cure for Parkinson’s disease, an upcoming experiment offers hope to the more than 10 million people living with the disorder that a breakthrough may be on the horizon. A team of ...